<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: flu vaccines</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'flu vaccines'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22flu+vaccines%22&t=%22flu+vaccines%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:54:17 +0100</lastBuildDate>
        <item>
            <title>FDA Keeps Scolding Vaccine Maker To No Avail</title>
            <link>http://www.medworm.com/index.php?rid=4953360&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FJ_ALGGujptA%2F</link>
            <description>If at first you don&amp;#8217;t succeed, try, try again? Last year at this time, the FDA chastised CSL, a big maker of flu vaccines based in Australia, for flunking an inspection that found several manufacturing deficiencies and, in addition to demanding a summary of corrective actions, agency officials took the unusual step of demanding a meeting with senior execs to review their plan (back story). 
Apparently, such meetings have absolutely no impact. The FDA has just issued a warning letter as a follow up to a March 2011 inspection, which generated a 483 report showing that CSL has no idea how to properly conduct an investigation to determine why fevers and convulsions were reported after children were given its products. Just the same, the FDA wants another meeting.
But how bad was the effo...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4953360</comments>
            <pubDate>Tue, 21 Jun 2011 14:09:08 +0100</pubDate>
            <guid isPermaLink="false">4953360</guid>        </item>
        <item>
            <title>When Flu Shots Go Wrong</title>
            <link>http://www.medworm.com/index.php?rid=3961796&amp;cid=t_288269_86_f&amp;fid=34445&amp;url=http%3A%2F%2Fwomenshealthnews.wordpress.com%2F2010%2F09%2F12%2Fwhen-flu-shots-go-wrong%2F</link>
            <description>I want to be very clear about this: I get flu shots. I think flu shots (and other vaccines) are a good thing. I will get them every year, especially as long as I work at a medical center. I really appreciate getting them for free, and the effort that goes into making that happen. I do not want my experience to in any way discourage anyone else from getting a flu shot, because what I experienced was completely unusual and probably the result of a new person having a bad day. I was not substantially harmed in any way, and got a good story to tell in the process. In the same manner, I have documented my blood drive mishaps here before, and I continue to donate blood and to encourage others to do so. Clear enough? 
With that out of the way, I got my annual flu shot last Tuesday. After register...</description>
            <author>Women's Health News</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3961796</comments>
            <pubDate>Sun, 12 Sep 2010 16:14:28 +0100</pubDate>
            <guid isPermaLink="false">3961796</guid>        </item>
        <item>
            <title>European Agency Reviews Glaxo Pandemic Vaccine</title>
            <link>http://www.medworm.com/index.php?rid=3911865&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FGyZBezQzMNo%2F</link>
            <description>The controversy over a GlaxoSmithKline pandemic vaccine is now prompting the European Medicines Agency to conduct a review after a &amp;#8220;limited number&amp;#8221; of cases of narcolepsy were reported following vaccination. Since last September, at least 30.8 million Europeans were vaccinated with Pandemrix, although most reports were filed in Sweden and Finland.
In a statement, the EMA says it&amp;#8217;s not clear whether vaccine caused the reaction, but the agency’s Committee for Medicinal Products for Human Use (CHMP) will look examine data to determine whether there is evidence for a causal association. At its meeting next month, the CHMP will consider whether there are any &amp;#8220;provisional measures&amp;#8221; that need to be taken.
The narcolepsy reaction has caused a stir in Finland, where ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3911865</comments>
            <pubDate>Fri, 27 Aug 2010 14:48:07 +0100</pubDate>
            <guid isPermaLink="false">3911865</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… The Weekend Nears</title>
            <link>http://www.medworm.com/index.php?rid=3911870&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F9LaUeTSAVOI%2F</link>
            <description>And so another work week will soon draw to a close. Not a moment too soon, yes? After all those meetings and deadlines, a respite is in order. We plan on spending time with two of our short people, catching up on sundry chores and maybe a nice drive somewhere with the radio turned up. What about you? Perhaps a day at the beach or a night at the movies? Whatever you do, go safely. See you soon and please do stay in touch&amp;#8230;
FDA Rejects Roche Breast Cancer Drug (Dow Jones)
Genzyme To Increase Shipments Of Rationed Drugs (Boston Globe)
Stallergenes Looks For US Marketing Partner (Bloomberg News)
Montana Governor Has New Plan For Cheaper Drugs (Associated Press)
FDA To Review Boehringer Ingelheim Blood Thinner Next Month (Reuters)
Clinical Trial Patients To Get Routine Care Covered (MSNBC)...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3911870</comments>
            <pubDate>Fri, 27 Aug 2010 11:59:09 +0100</pubDate>
            <guid isPermaLink="false">3911870</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=3790925&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FFPKkiqBmLug%2F</link>
            <description>Hello, everyone, and welcome back. We hope your weekend was relaxing. Now, of course, the routine returns as meetings and deadlines loom. At least the heat wave has broken, as measured by a rare, cool breeze now wafting through the Pharmalot corporate campus. So please join us for the mandatory cup of stimulation as we prepare for another day. One note: we will be speaking later on an industry panel, so please excuse the interruption in our usual schedule. Meanwhile, have a good one and stay in touch&amp;#8230;.
Onyx Posts Positive Results For Cancer Drug (Associated Press)
Sanofi Cuts Forecast After FDA Approves Generic Lovenox (Bloomberg News)
The Brilinta Guessing Game As FDA Panel Nears (Reuters)
Eisai Gets Boost From FDA OK For Higher-Dose Aricept (PharmaTimes)
Genzyme Is Seen As More Att...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3790925</comments>
            <pubDate>Mon, 26 Jul 2010 12:00:41 +0100</pubDate>
            <guid isPermaLink="false">3790925</guid>        </item>
        <item>
            <title>FDA Scolds Vaccine Maker And Asks For A Sit Down</title>
            <link>http://www.medworm.com/index.php?rid=3706993&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FNJj_HyWGF4o%2F</link>
            <description>In what may be a new get-tough program at the FDA, the agency issued a so-called untitled letter to CSL, a big maker of flu vaccines based in Australia, for flunking an April inspection that found several manufacturing deficiencies. And in addition to demanding a summary of corrective actions that must be taken, FDA officials want to meet with CSL senior execs to review their plan. 
The move comes less than a month after CSL recalled its seasonal shot for children in Australia after investigations failed to explain a nine-fold increase in fever and convulsions. However, the FDA also issued a Q&amp;#038;A in which the agency says the manufacting issues are unrelated to the problems that spurred the recall (background here and here). 
The FDA cited CSL for &amp;#8220;a number of significant objectio...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3706993</comments>
            <pubDate>Mon, 28 Jun 2010 20:42:34 +0100</pubDate>
            <guid isPermaLink="false">3706993</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=3618092&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FVcXlT15h6x4%2F</link>
            <description>Welcome back. We hope you had a nice weekend. It was a long one here in the states. Now, of course, the routine has returned and that means a to-do list complete with meetings and deadlines. So grab that cup of stimulation and get ready for another day. To help you along, here are a few items of interest. Have a good one and stay in touch&amp;#8230;
Glaxo Settles More Avandia Lawsuits (Reuters)
AstraZeneca Gets Complete Response Letter For Axanum (Bloomberg News)
EMA Urges Cooperation On Overseas Trials (Outsourcing Pharma)
UK&amp;#8217;s NICE Rejects Novartis&amp;#8217; Xolair For Children (Reuters)
CSL Recalls Flu As Side Effects Rise (Bloomberg News)
Singapore Considers Mandatory HPV Vaccination (AsiaOne)
Elan Optimistic On Sale Of Drug Delivery Unit (InPharmaTechnologist) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3618092</comments>
            <pubDate>Tue, 01 Jun 2010 12:03:14 +0100</pubDate>
            <guid isPermaLink="false">3618092</guid>        </item>
        <item>
            <title>WHO Panel To Get Pharma Swine Flu Documents</title>
            <link>http://www.medworm.com/index.php?rid=3577622&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FN2Mz6xyOy2c%2F</link>
            <description>A panel investigating the World Health Organization&amp;#8217;s response to last year&amp;#8217;s swine flu outbreak wants to see confidential exchanges between the agency and drugmakers. The 29-member panel wants WHO records and correspondence from before and after the H1N1 strain was declared a pandemic in June, the Associated Press reports.
&amp;#8220;We will want to have access to certain confidential documents that may be in place here at WHO or elsewhere,&amp;#8221; committee chair Harvey Fineberg, who is also president of the Institute of Medicine in Washington, told reporters in Geneva, adding that documents include &amp;#8220;contractual or letters of understanding&amp;#8221; between the WHO and drugmakers. Some agreements have been considered confidential, but so far all requests have been met. The pane...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3577622</comments>
            <pubDate>Wed, 19 May 2010 15:45:07 +0100</pubDate>
            <guid isPermaLink="false">3577622</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… The Weekend Nears</title>
            <link>http://www.medworm.com/index.php?rid=3499311&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FgAQqzpPFA-Q%2F</link>
            <description>And so another work week is about to draw to a close. What are you planning for the weekend? Mowing the lawn? Riding a bike? A walk in the park? We look forward to spending time with our short and not-so-short people and running with the official Pharmalot mascot. While you ponder your own choices, here are a few items to help you round out the day. Have a nice time, whatever you do and see you soon&amp;#8230;
Australia Tells Docs To Stop Kids&amp;#8217; Flu Shot (Bloomberg News)
J&amp;#038;J Shareholders Reject Say-On-Pay Proposal (Associated Press)
EU Sees Genzyme Drug Shortage Through September (Reuters)
Pfizer Ends Trial Of Sutent In Liver Cancer (Associated Press)
EMA Backs Nycomed COPD Drug (Reuters)
EU Approves Diovan For Children (Associated Press)
Roche Files For New Herceptin Use In US (Reut...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3499311</comments>
            <pubDate>Fri, 23 Apr 2010 11:43:46 +0100</pubDate>
            <guid isPermaLink="false">3499311</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=3487371&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FOyT2YYMmp-E%2F</link>
            <description>Rise and shine. Another day beckons. And this is a special one here on the Pharmalot corporate campus as one of the short people celebrates a birthday. An especially large cup of stimulation is in order…among other things. While we fuss, please enjoy these items and, of course, have a nice day…
Acura Pharma Has FDA Panel Meeting (TheStreet)
Biogen Profit Falls, Tysabri Sales Rise (Reuters)
Boehringer-Ingelheim Considers More Takeovers (Bloomberg News)
J&amp;#038;J Drug Sales Slump (Reuters)
Novartis Profit Rises On Flu Vaccines (Bloomberg News)
Roche Arthritis Drug Meets Goal, Safety Issues Linger (Reuters)
Raloxifene And Tamoxifen Both Guard Against Breast Cancer (HealthDay)
Array Signs $467M Deal With Novartis (Reuters) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3487371</comments>
            <pubDate>Tue, 20 Apr 2010 11:58:36 +0100</pubDate>
            <guid isPermaLink="false">3487371</guid>        </item>
        <item>
            <title>WHO Experts Deny Pharma Influenced H1N1 Vaccine</title>
            <link>http://www.medworm.com/index.php?rid=3472044&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FF27q-IJVyI0%2F</link>
            <description>The experts involved in the World Health Organization decision to declare a flu pandemic rejected accusations of undue influence from drugmakers, and insisted that &amp;#8220;meticulous care&amp;#8221; was taken to avoid conflicts of interest and to keep a distance from industry as much as possible, Agence France-Presse writes.
David Salisbury, of the WHO&amp;#8217;s standing Strategic Advisory Group of Experts (SAGE) on immunization and a director of immunization at the UK&amp;#8217;s Department of Health, said candidates for the advisory body were vetted before they joined and those with conflicts of interest were excluded. &amp;#8220;There has been no declaration of conflict from any SAGE member in our proceeding on A (H1N1) vaccine,&amp;#8221; he told a probe investigating the international response to the pa...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3472044</comments>
            <pubDate>Thu, 15 Apr 2010 11:59:57 +0100</pubDate>
            <guid isPermaLink="false">3472044</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=3443983&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FPHedEVOSc7Y%2F</link>
            <description>Good morning, everyone. Hope your week is going well. We are on an altered scheduled, as it so happens, but have a nifty system to keep you abreast of developments. And so here are a few that we hope will ease your day. Meanwhile, we are grabbing the required cup of stimulation - we go nowhere without one - and invite you to do the same. Stay in touch&amp;#8230;
Prescription Drug Overdoses Rise In The US (Reuters)
Sanofi Chemo Drug Pact Should Draw FTC Scrutiny (Seeking Alpha)
AIDS Group Asks Bristol To Cut Drug Price (press release)
UK Cuts Swine Flu Vaccine Order (Associated Press)
Merck Drug Shows Promise In Pelvic Cancer Patients (Reuters)
Clearstone To Close New Jersey Lab (OutsourcingPharma) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3443983</comments>
            <pubDate>Wed, 07 Apr 2010 12:16:20 +0100</pubDate>
            <guid isPermaLink="false">3443983</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… The Weekend Nears</title>
            <link>http://www.medworm.com/index.php?rid=3220740&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fi-uFJZLh3Zw%2F</link>
            <description>And so another week draws to a close. We hope you survived. What will you do this weekend? Errands? Taxes? How about something relaxing? While you contemplate, another day beckons, so here are a few items to help you get by. Whatever you do this weekend, we hope you have time for something refreshing. Enjoy, everyone, and see you next week&amp;#8230;
Novartis Warns Countries Over Cancelled Vaccine Orders (AFP)
Merck Helicopter Pad Site Approved (nj.com)
Judge Rules Drugmakers Overcharged New York (Bloomberg News)
Alberta, Canada To Save Millions On Generics (Edmonton Journal)
Mississippi Senate Panel OKs Rx For Cold Meds (Associated Press)
photo thx to tipiro on Flickr creative commons (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3220740</comments>
            <pubDate>Fri, 29 Jan 2010 12:31:47 +0100</pubDate>
            <guid isPermaLink="false">3220740</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=3205117&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F8zWL0UIlaCQ%2F</link>
            <description>Welcome to the working week. We hope your weekend was refreshing and invigorating. Now, though, the time has come to return to the usual pile of meetings and deadlines. To arm ourselves, we are brewing the usual cup(s) of stimulation and scouring about for a few interesting items. We have uncovered this much so far. Hope your day goes well and stay in touch&amp;#8230;
Alcon Investor Expects Higher Novartis Bid (Reuters)
China To Open Market To Indian Drugmakers (PharmaTimes)
Venture Capitalists Reduced Biotech Funding (Boston.com)
Japanese Market Forecast To Plummet (OutsourcingPharma)
Welsh MP Slams Swine Flu Vaccine Makers (WalesOnline)
Amylin Braces For Once-Weekly Diabetes Drug (Xconomy.com)
PPD Sells Biomaker Biz To Caprion (OutsourcingPharma)
Coffee thanks to chichcacha Flickr Common Cre...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3205117</comments>
            <pubDate>Mon, 25 Jan 2010 12:35:08 +0100</pubDate>
            <guid isPermaLink="false">3205117</guid>        </item>
        <item>
            <title>Weekend Reading… On The Couch</title>
            <link>http://www.medworm.com/index.php?rid=3137649&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FIu_VuYVe7SE%2F</link>
            <description>Hello, everyone. Hope your holiday break was fun and while you continue to unwind, we thought it might be helpful to offer you a few minutes of interesting reading. Meanwhile, we hope to brave the brisk winds to walk our faithful friend shortly. So we’ll leave you with these items for now and resume the usual routine tomorrow. Hope your weekend is going well and you enjoy yourselves&amp;#8230;
James Goddard, a former FDA commish who was credited with overhauling the agency’s methods for evaluating drugs, died last week of a brain hemorrhage. From 1966 to 1968, he cracked down on exaggerated drug ads, delayed approval of new drug applications until drugmakers backed them up with more testing, and campaigned to take ineffective drugs off the market. A fly in industry&amp;#8217;s ointment, he was...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3137649</comments>
            <pubDate>Sun, 03 Jan 2010 14:30:31 +0100</pubDate>
            <guid isPermaLink="false">3137649</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… The Weekend Nears</title>
            <link>http://www.medworm.com/index.php?rid=3101065&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FESz8h25b33Q%2F</link>
            <description>And so another week is about to draw to a close. And not a moment too soon, yes? What will you do this weekend? Take a brisk walk? Catch up on sleep? Stimulate the economy by doing a little shopping? We will be shuttling assorted short people to and from all sorts of things, as always. But there is hope we can catch up on some paperwork and reading. While you ponder your own possibilities, here are a few items to help you start the day. Have a great weekend, everyone&amp;#8230;
Low Demand For Flu Vaccine Hurts Suppliers (The Financial Times)
USPTO Upholds Merck&amp;#8217;s Singulair Patent (Reuters)
Eisai Buys AkaRx For $255 Million (Reuters)
Photo courtesy of Flickr tipiro (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3101065</comments>
            <pubDate>Fri, 18 Dec 2009 11:38:56 +0100</pubDate>
            <guid isPermaLink="false">3101065</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Morning Edition</title>
            <link>http://www.medworm.com/index.php?rid=3023414&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fcuc_inec6oM%2F</link>
            <description>Hello, again. Gray skies are hovering over the Pharmalot corporate campus this morning and are expected to remain here awhile. Just the same, our outlook is sunny. And why not? This is a short week. So here are a few items to help you keep your own spirits high. Have a nice day, everyone&amp;#8230;
BioCryst Blames Conspiracy For Stock Decline (TheStreet.com)
Pfizer Waffles On La Jolla Incubator (San Diego Business Journal)
Glaxo Blames Admin Error For Yanking Avodart sNDA (PharmaTimes)
Glaxo Holds Some Swine-Flu Shots In Canada (Bloomberg News) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3023414</comments>
            <pubDate>Tue, 24 Nov 2009 13:24:03 +0100</pubDate>
            <guid isPermaLink="false">3023414</guid>        </item>
        <item>
            <title>Connecticut Attorney Gen’l Probes Vaccine Makers</title>
            <link>http://www.medworm.com/index.php?rid=2954800&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FpIV5VhcUHF4%2F</link>
            <description>The state is investigating complaints of price fixing and preferential treatment in the distribution of seasonal flu vaccine. Attorney General Richard Blumenthal&amp;#8217;s office told reporters it has written to 13 manufacturers and distributors of seasonal flu vaccine, requesting details on price, supply levels and distribution methods by Nov. 15, Reuters writes.
Seasonal flu vaccine is in short supply, in part, because distribution has swung to the H1N1 swine flu vaccine. Blumenthal said his office has received complaints of seasonal flu vaccine being offered at many times the normal price, and of distributors and manufacturers reneging on previously negotiated price agreements.
The vaccine makers contacted by Blumenthal&amp;#8217;s office about alleged price gouging were Sanofi-Pasteur, a uni...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2954800</comments>
            <pubDate>Mon, 02 Nov 2009 23:45:27 +0100</pubDate>
            <guid isPermaLink="false">2954800</guid>        </item>
        <item>
            <title>What If Flu Vaccines Can’t Really Protect Us?</title>
            <link>http://www.medworm.com/index.php?rid=2908890&amp;cid=t_288269_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FTPkL0fYh15w%2F</link>
            <description>The ongoing debate over vaccines is, not surprisingly, extended to swine flu now that a pandemic has been declared and, as The Atlantic points out, the US government has mounted its most ambitious vaccination program since the anti-polio campaign in the 1950s. Five companies, you may recall, were commissioned to produce enough vaccine to cover the entire US population. 
The mag also reminds us that the CDC has recommended 159 million adults and children receive either a swine flu shot or a dose of MedImmune’s nasal vaccine this year. Shots are offered in doctors’ offices, hospitals, airports, pharmacies, schools, polling places, shopping malls, and big-box stores like Wal-Mart. And the federal government has spent upwards of $3 billion stockpiling millions of doses of antiviral drugs l...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2908890</comments>
            <pubDate>Tue, 20 Oct 2009 12:07:18 +0100</pubDate>
            <guid isPermaLink="false">2908890</guid>        </item>
        <item>
            <title>Giant Food Chain Offers Low Cost Flu Shots</title>
            <link>http://www.medworm.com/index.php?rid=2786112&amp;cid=t_288269_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FmXJ7Z82_-aY%2F</link>
            <description>The Giant Food grocery chain, which has markets in VA, MD, and DC, is will be offering low cost seasonal flu vaccines to its customers. Of 181 stores, 164 have full-service pharmacies, where these flu vaccinations will be offered.
According to a press release issued earlier today, vaccination program will begin
Friday September 11, expanding to all stores in October. Immunizations will be provided by certified and trained Giant pharmacists and through Giant&amp;#8217;s partnership with Maxim Health Systems and their trained health care professionals. The cost of the seasonal immunization is $30, but customers with a Giant loyalty card can save an additional $10. Thus, the final cost to Giant customers, with the Card, is $20.
The seasonal flu shot changes from year to year and is developed on t...</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2786112</comments>
            <pubDate>Thu, 10 Sep 2009 18:31:49 +0100</pubDate>
            <guid isPermaLink="false">2786112</guid>        </item>
        <item>
            <title>Swine Flu Vaccine Priorities from the CDC</title>
            <link>http://www.medworm.com/index.php?rid=2660662&amp;cid=t_288269_86_f&amp;fid=34445&amp;url=http%3A%2F%2Fwomenshealthnews.wordpress.com%2F2009%2F07%2F31%2Fswine-flu-vaccine-priorities-from-the-cdc%2F</link>
            <description>The CDC&amp;#8217;s Advisory Committee on Immunization Practices met this week to discuss which groups should receive the H1N1 swine flu vaccine when it becomes available if there is not enough for everyone. 
The groups prioritized to receive the vaccine first/if there is limited supply are:

Pregnant women
Household contacts and caregivers for children younger than 6 months of age
Healthcare and emergency medical services personnel
All people from 6 months through 24 years of age
Persons aged 25 through 64 years who have health conditions associated with higher risk of medical complications from influenza.
The CDC&amp;#8217;s website provides a rationale for each of these selections. The groups combined apparently total approximately 159 million people in the United States, according to this CDC ...</description>
            <author>Women's Health News</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2660662</comments>
            <pubDate>Fri, 31 Jul 2009 13:50:51 +0100</pubDate>
            <guid isPermaLink="false">2660662</guid>        </item>
    </channel>
</rss>

